Signaling capacity of FcγRII isoforms in B-CLL cells

Leukemia Research

Volumn 29, Issue 11, 2005, Pages 1277-1284

  Gamberale, Romina ^a,b   Fernández Calotti, Paula ^a,b   Sanjurjo, Julieta ^a,b   Arrossagaray, Guillermo ^a   Avalos, Julio Sánchez ^c   Geffner, Jorge ^a,b   Giordano, Mirta ^a,b  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

B CLL; Fc RIIA; Fc RIIB

Indexed keywords

FC RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 3; RECEPTOR SUBTYPE; TYROSINE; FC GAMMA RECEPTOR IIA; FC GAMMA RECEPTOR IIB; ISOPROTEIN; LEUKOCYTE ANTIGEN;

ADULT; AGED; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; CALCIUM MOBILIZATION; CHRONIC LYMPHATIC LEUKEMIA; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL; MALE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPLEEN CELL; TONSIL CELL; CELL SURVIVAL; IMMUNOLOGY; MIDDLE AGED; TUMOR CELL LINE;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; PROTEIN ISOFORMS; RECEPTORS, IGG;

EID: 24744462290     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.04.008     Document Type: Article

References (42)

1. M. Daeron Structural bases of Fc gamma R functions Int Rev Immunol 16 1997 1 27
2. I.A. Heijnen, and J.G. van de Winkel Human IgG Fc receptors Int Rev Immunol 16 1997 29 55
3. J.V. Ravetch, and S. Bolland IgG Fc receptors Ann Rev Immunol 19 2001 275 290
4. K.M. Coggeshall Inhibitory signaling by B cell FcγRIIB Curr Opin Immunol 10 1998 306 312
5. J.V. Ravetch, and L.L. Lanier Immune inhibitory receptors Science 290 2000 84 89
6. R.N. Pearse, T. Kawabe, S. Bolland, R. Guinamard, T. Kurosaki, and J.V. Ravetch SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis Immunity 10 1999 753 760
7. R. Gamberale, M. Giordano, A.S. Trevani, G. Andonegui, and J.R. Geffner Modulation of human neutrophil apoptosis by immune complexes J Immunol 161 1998 3666 3674
8. J.T. Kim, A.W. Schimming, and H. Kita Ligation of FcγRII (CD32) pivotally regulates survival of human eosinophils J Immunol 162 1999 4253 4259
9. T.J. Hamblin, and D.G. Oscier Chronic lymphocytic leukaemia: the nature of the leukaemic cell Blood Rev 11 1997 119 128
10. F. Caligaris-Cappio, and T.J. Hamblin B-cell chronic lymphocytic leukemia: a bird of a different feather J Clin Oncol 17 1999 399 408
11. N. Chiorazzi, and M. Ferrarini B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor Ann Rev Immunol 21 2003 841 894
12. R. Gamberale, J.R. Geffner, J. Sanjurjo, P. Fernández-Calotti, G. Arrosagaray, and J. Sánchez Avalos Expression of Fcγ receptors type II (FcγRII) in chronic lymphocytic leukemia B cells Blood 102 2003 2698 2699
13. R. Gamberale, J.R. Geffner, and M. Giordano Immune complexes and apoptosis in B-cell chronic lymphocytic leukemia Leuk Lymphoma 43 2002 251 255
14. N. Laytragoon-Lewin, E. Duhony, X.F. Bai, and H. Mellstedt Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells Eur J Haematol 61 1998 266 271
15. S. Zupo, L. Isnardi, M. Megna, R. Massara, F. Malavasi, and M. Dono CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis Blood 88 1996 1365 1374
16. M. Semichon, H. Merle-Beral, V. Lang, and G. Bismuth Normal Syk protein level but abnormal tyrosine phosphorylation in B-CLL cells Leukemia 11 1997 1921 1928
17. S. Lanham, T. Hamblim, D. Oscier, R. Ibbotson, F. Stevenson, and G. Packham Differential signaling vía surface IgM is associated with Vh gene mutation status and CD38 expression in chronic lymphocytic leukemia Blood 101 2003 1087 1093
18. J.O. Pers, C. Berthou, N. Porakishvili, M. Burdjanadze, G. Le Calvez, and J.F. Abgrall CD-5 induced apoptosis of B cells in some patients with chronic lymphocytic leukemia Leukemia 16 2002 44 52
19. E. Harlow, and D. Lane Antibodies: a laboratory manual 1988 Cold Spring Harbor Laboratory Cold Spring Harbor, NY p. 628-9
20. R. Gamberale, J.R. Geffner, G. Arrosagaray, M. Scolnik, G. Salamone, and A. Trevani Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis Leukemia 15 2001 1860 1867
21. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober Isolation of mononuclear cell from tonsillar tissue Current protocols in immunology 1994 John Wiley and Sons Bethesda, MD p. 7.8.1-3
22. J.E. Coligan, A.M. Kruibeed, D.H. Margulies, E.M. Shevach, and W. Stroeber Morphological and biochemical assays of apoptosis Current protocols in immunology 1994 John Wiley and Sons Bethesda, MD p. 3.17.1-6
23. I. Nicoletti, M.C. Migliorati, C. Pagliacci, F. Grignani, and C. Ricciardi A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry J Immunol Methods 139 1991 271 279
24. L. Pricop, J. Gokhale, P. Redecha, S.C. Ng, and J.E. Salmon Reactive oxygen intermediates enhance Fcg receptor signaling and amplify phagocytic capacity J Immunol 162 1999 7041 7048
25. D.L. Maresco, J.M. Osborne, D. Cooney, K.M. Coggeshall, and C.L. Anderson The SH2-containing 5-inositol phosphatase (SHIP) is tyrosine phosphorylated after Fcγ receptor clustering in monocytes J Immunol 162 1999 6458 6465
26. S. Tridandapani, K. Siefker, J.L. Teillaud, L.E. Carter, M.D. Wewers, and C.L. Anderson Regulated expression and inhibitory function of FcγRIIb in human monocytic cells J Biol Chem 277 2002 5082 5089
27. L.P. Ganesan, H. Fang, C.B. Marsh, and S. Tridandapani The protein-tyrosine phosphatase SHP-1 associates with the phosphorylated immunoreceptor tyrosine-based activation motif of FcγRIIA to modulate signaling events in myeloid cells J Biol Chem 278 2003 35710 35717
28. P. Panayiotidis, K. Ganeshaguru, S.A. Jabbar, and A.V. Hoffbrand Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro Br J Haematol 85 1992 439 445
29. M. Dancescu, M. Rubio-Trujillo, G. Biron, D. Bron, G. Delespesse, and M. Sarfati Interleukin-4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression J Exp Med 176 1992 1319 1326
30. M.E. Kay, and B.Y. Pittner IL-4 biology: impact on normal and leukemic CLL B cells Leuk Lymphoma 44 2003 897 903
31. O. Katsumata, M. Hara-Yokoyama, and C. Sautes-Fridman Association of FcgammaRII with low-density detergent-resistant membranes is important for cross-linking-dependent initiation of the tyrosine phosphorylation pathway and superoxide generation J Immunol 167 2001 5814 5823
32. Z.Y. Huang, S. Hunter, M.K. Kim, Z.K. Indik, and A.D. Schreiber The effect of phosphatases SHP-1 and SHIP-1 on signaling by the ITIM- and ITAM-containing Fcgamma receptors FcγRIIB and FcγRIIA J Leuk Biol 73 2003 823 829
33. A. Pinto, L. Del Vecchio, A. Carbone, M. Roncadin, R. Volpe, and D. Serraino Expression of myelomonocytic antigens is associated with unfavourable clinicoprognostic factors in B-cell chronic lymphocytic leukaemia Ann Oncol 2 1991 107 113
34. D. Tassies, E. Montserrat, J.C. Reverter, N. Villamor, M. Rovira, and C. Rozman Myelomonocytic antigens in B-cell chronic lymphocytic leukemia Leuk Res 19 1995 841 848
35. V. Callea, F. Morabito, B.M. Oliva, C. Stelitano, D. Levato, and A. Dattilo Surface CD14 positivity in B-cell chronic lymphocytic leukaemia is related to clinical outcome Br J Haematol 107 1999 347 352
36. T. Muta, T. Kurosaki, Z. Misulovin, M. Sanchez, M.C. Nussenzweig, and J.V. Ravetch A 13-aminoacid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling Nature 369 1994 340
37. A.M. Brauweiler, and J.C. Cambier FcγRIIB activation leads to inhibition of signaling by independently ligated receptors Biochem Soc Trans 31 2003 281 285
38. B.M. Broker, A. Klajman, P. Youinou, J. Jouquan, C.P. Worman, and J. Murphy Chronic lymphocytic leukemic (CLL) cells secrete multispecific autoantibodies J Autoimmun 1 1988 469 475
39. Z.M. Sthoeger, M. Wakai, D.B. Tse, V.P. Vinciguerra, S.L. Allen, and D.R. Budman Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia J Exp Med 169 1989 255 263
40. L. Borche, A. Lim, J.L. Binet, and G. Dighiero Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies Blood 76 1990 562 573
41. O. Pritsch, C. Magnac, G. Dumas, C. Egile, and G. Dighiero V gene usage by seven hybrids derived from CD5+ B-cell chronic lymphocytic leukemia and displaying autoantibody activity Blood 82 1993 3103 3112
42. P.A. Ramsland, C.R. Brock, J. Moses, B.G. Robinson, A.B. Edmundson, and R.L. Raison Structural aspects of human IgM antibodies expressed in chronic B lymphocytic leukemia Immunotechnology 4 1999 217 229